Activity of matrix metalloproteinase-2 and -9 and contents of their tissue inhibitors in uterine leiomyoma and corresponding myometrium

Gynecological Endocrinology

Volumn 23, Issue 9, 2007, Pages 541-546

  Bogusiewicz, Michał ^a   Stryjecka Zimmer, Marta ^a   Postawski, Krzysztof ^a   Jakimiuk, Artur J ^a,b   Rechberger, Tomasz ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^b MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

Author keywords

Collagen; Metalloproteinase; Uterine leiomyoma

Indexed keywords

COLLAGEN TYPE 4; GELATINASE A; GELATINASE B; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ADULT; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME LOCALIZATION; EXTRACELLULAR MATRIX; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOLOCALIZATION; MUSCLE CELL; MYOMETRIUM; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER; UTERUS MYOMA; ZYMOGRAPHY;

COLLAGEN TYPE IV; FEMALE; HUMANS; LEIOMYOMA; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; MYOMETRIUM; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2; UTERINE NEOPLASMS;

EID: 35448980239     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.1080/09513590701557416     Document Type: Article

References (21)

1. Wallach EE. Leiomyomas. In: Wallach EE, Zacur HA, editors. Reproductive medicine and surgery. St. Louis (MO): Mosby; 1994. pp 731-746.
2. Stewart EA. Uterine fibroids. Lancet 2001;357:293-298.
3. Maruo T, Matsuo H, Samoto T, Shimomura Y, Karachi O, Gao Z, Wang Y, Spitz IM, Johansson E. Effects of progesterone on uterine leiomyoma growth and apoptosis. Steroids 2000;65:585-592.
4. Sozen I, Arici A. Interactions of cytokines, growth factors, and the extracellular matrix in the cellular biology of the uterine leiomyomata. Fertil Steril 2002;78:1-12.
5. Fujita M. Histological and biochemical studies of collagen in human uterine leiomyomas. Hokkaido Igaku Zasshi 1985;60:602-615.
6. Wegrowski Y, Bellon G, Quereux C, Maquart F-X. Biochemical alterations of uterine leiomyoma extracellular matrix in type IV Ehlers-Danlos syndrome. Am J Obstet Gynecol 1999;180:1032-1034.
7. Wolańska M, Sobolewski K, Bańkowski E, Jaworski S. Matrix metalloproteinases of human leiomyoma in various stages of tumor growth. Gynecol Obstet Invest 2004;58:14-18.
8. Hulboy DL, Rudolph LA, Matrisian LM. Matrix metalloproteinases as mediators of reproductive function. Mol Hum Reprod 1997;3:27-45.
9. Nagase H, Woessner JF Jr. Matrix metalloproteinases. J Biol Chem 1999;274:21491-21494.
10. Coussens LM, Werb Z. Matrix metalloproteinases and the development of cancer. Chem Biol 1996;3:895-904.
11. Woessner JF Jr. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J 1991;5:2145-2154.
12. Dou Q, Tranuzzer RW, Wiliams RS, Schultz GS, Chegini N. Differential expression of matrix metalloproteinases and their tissue inhibitors in leiomyomata: a mechanism for gonadotrophin releasing hormone agonist-induced tumor regression. Mol Hum Reprod 1997;3:1005-1014.
13. Bodner-Adler B, Bodner K, Kimberger O, Czerwenka K, Leodolter S, Mayerhofer K. Expression of matrix metalloproteinases in patients with uterine smooth muscle tumors: an immunohistochemical analysis of MMP-1 and MMP-2 protein expression in leiomyoma, uterine smooth muscle tumor of uncertain malignant potential, and leiomyosarcoma. J Soc Gynecol Investig 2004;11:182-186.
14. Woessner JF Jr. Quantification of matrix metalloproteinases in tissue samples. Methods Enzymol 1995;248:510-528.
15. Cadman E, Bastwick IB, Eichberg I. Determination of protein by a modified Lowry procedure in the presence of commonly used detergents. Anal Biochem 1979;96:21-23.
16. Hibbs MS, Hasty KA, Seyer JM, Kang AH, Mainard CL. Biochemical and immunological characterization of the secreted forms of human neutrophil gelatinase. J Biol Chem 1985;260:2493-2500.
17. Moiseva EP. Adhesion receptors of vascular smooth muscle cells and their functions. Cardiovasc Res 2001;52:372-386.
18. You Q, Stamenkovic I. Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-β and promotes tumor invasion and angoigenesis. Genes Dev 2000;14:163-176.
19. Fowleks JL, Enghild JJ, Suzuki K, Nagase H. Matrix metalloproteinase degrade insulin-like growth factor binding ptotein-3 in dermal fibroblast cultures. J Biol Chem 1994;269:25742-25746.
20. Wingrove CS, Garr E, Godsland IF, Stevenson JC. 17β-Estradiol enhances release of matrix metalloproteinase-2 from human vascular smooth cells. Biochim Biophysis Acta 1998;1406:169-174.
21. Butler GS, Will H, Atkinson SJ, Murphy G. Membrane-type-2 matrix metalloproteinase can initiate the processing of progelatinase and is regulated by the tissue inhibitors of metalloproteinases. Eur J Biochem 1997;244:653-657.